Cabaletta Bio, Inc. (CABA) Tops Q4 EPS by 6c

Cabaletta Bio, Inc. (NASDAQ: CABA) reported Q4 EPS of ($0.40), $0.06 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Cabaletta Bio, Inc. (CABA) click here.

You May Also Be Interested In

• Benchmark initiates Synopsys, Cadence with Buy ratings on AI-driven EDA outlook
• Standard Nuclear indicating to open at $15-$16, IPO priced at $15
• J.B. Hunt Transport Services (JBHT) PT Raised to $291 at UBS